SCHEMBL16924930

SCHEMBL16924930

CC(C)Oc1ccc(C(=O)CF)cc1[N+](=O)[O-]

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.66
▸ ALDH1A1 P00352 5/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ CYP3A4 P08684 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ XDH P47989 1/20 0.44
▸ THRA P10827 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ LMNA P02545 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ PRSS1 P07477 3/20 0.42
▸ EP300 Q09472 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16924922 0.86 PDK1 (0.70) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL31439591 0.83 PDK1 (0.62) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL8800296 0.83 PDK1 (0.72) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL2550259 0.83 PDK1 (0.72) PDK1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL6112853 0.82 PDK1 (0.71) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL28748723 0.82 PDK1 (0.75) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL16956345 0.81 PDK1 (0.70) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL16924905 0.81 PDK1 (0.66) PDK1ALDH1A1SMN1; SMN2CYP3A4TSHR
SCHEMBL6113956 0.81 PDK1 (0.69) PDK1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL31439475 0.81 PDK1 (0.69) PDK1ALDH1A1CYP3A4TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938245-B2 Carbonyl erastin analogs and their use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-04-10 — — US disclosed
US-9938245-B2 Carbonyl erastin analogs and their use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-04-10 — — US disclosed
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2016-11-17 — — US disclosed
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2016-11-17 — — US disclosed
WO-2015109009-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-07-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE KEAP1, GPX1, GPX4 PDK1 673/4885ALDH1A1 407/4885SMN1; SMN2 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback